These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27644904)

  • 1. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction.
    Hulshof MC; van Laarhoven HW
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):551-63. PubMed ID: 27644904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
    Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
    Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction.
    von Döbeln GA; Wagenius G; Holtved E; Jacobsen AB; Nilsson M; Yu J; Baeksgaard L
    Cancer Treat Res Commun; 2020; 24():100187. PubMed ID: 32619832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.
    Bystricky B; Okines AF; Cunningham D
    Drugs; 2011 Mar; 71(5):541-55. PubMed ID: 21443280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
    Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive chemoradiotherapy.
    Stahl M; Budach W
    J Thorac Dis; 2017 Jul; 9(Suppl 8):S792-S798. PubMed ID: 28815076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.
    Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Lind PA; Lindblad M; Ye W; Lundell L; Schuhmacher C; Mauer M; Burmeister BH; Thomas JM; Stahl M; Nilsson M
    Eur J Surg Oncol; 2015 Mar; 41(3):282-94. PubMed ID: 25491892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
    Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
    Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-operative chemotherapy in patients with oesophageal and gastro-oesophageal junction cancer - three years of experience.
    Pechačová Z; Zemanová M; Haruštiak T; Vítek P; Fencl P
    Prague Med Rep; 2013; 114(2):57-71. PubMed ID: 23777797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
    Sandler S
    Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
    Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.
    van der Woude SO; Hulshof MC; van Laarhoven HW
    Chin Clin Oncol; 2016 Feb; 5(1):13. PubMed ID: 26932437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
    Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
    Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multimodal therapy of esophageal cancer].
    Hartwig W; Strobel O; Lordick F; Büchler MW; Werner J
    Z Gastroenterol; 2008 Oct; 46(10):1207-13. PubMed ID: 18937192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy.
    Honing J; Koch AD; Siersema PD; Spaander M
    Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101885. PubMed ID: 38522883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy.
    Calvo FA; Sole CV; Obregón R; Gómez-Espí M; Lozano MA; Gonzalez-Bayon L; García-Sabrido JL
    Ann Surg Oncol; 2013 Jun; 20(6):1962-9. PubMed ID: 23254690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.